Effect of heart procedure on thinking skills in older adults with mild cognitive impairment
Official title: EfFect of Ablation of Persistent AtriaL Fibrillation on COgNitive Function in Individuals With Mild Cognitive Impairment : - The FALCON Study-
Run by Poitiers University Hospital · NCT05790707 · Data updated 2026-11-12
This study is testing if a heart procedure combined with medication can help improve thinking skills in older adults with mild cognitive impairment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years to 80 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Poitiers University Hospital Academic / other |
| Locations | 8 sites (Angers and 7 other locations) |
| Status | Recruiting |
| Started | April 21, 2023 |
| Main results expected | January 2027 |
| Study ends | July 2027 |
| Registry record updated | January 23, 2026 |
| Trial ID | NCT05790707 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 60 to 85 with persistent atrial fibrillation and mild cognitive impairment.
✕Probably not a fit
Patients with a history of clinical stroke or neurodegenerative diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to assess how catheter ablation of persistent atrial fibrillation impacts cognitive function in individuals aged 60 to 85 with mild cognitive impairment. Participants will be randomly assigned to receive either antiarrhythmic drugs alone or a combination of atrial fibrillation ablation and antiarrhythmic drugs. The study will evaluate cognitive changes using standardized assessments to determine the effectiveness of the intervention. The goal is to provide insights into the relationship between heart rhythm control and cognitive health.
Why it matters
Potential benefit: If successful, this study could improve cognitive function in patients with mild cognitive impairment by addressing underlying atrial fibrillation.
How similar studies have gone: While there is limited data on this specific approach, similar studies have suggested potential cognitive benefits from managing atrial fibrillation, making this a promising area of investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 60 to 80 years * Persistent atrial fibrillation * Patients with an indication for cardiac rhythm control. * Montreal Cognitive Assessment score between 18 and 25 points corresponding to mild cognitive impairment * Free subject, not under temporary or permanent guardianship and not subject to subordination * Subject understanding and accepting the constraints of the study * Patient covered by French national health insurance or benefiting from it through a third party * Subject has given written consent to the study after having received clear and complete information Exclusion Criteria: * Impossibility to perform the neuropsychological evaluation (communication problems such as hearing loss or aphasia, language barrier) * History of clinical stroke * Presence of a bruit at carotid auscultation or history of severe carotid stenosis * History or suspicion of neurodegenerative disease (Parkinson's disease, Alzheimer's disease, Huntington's disease and amyotrophic lateral sclerosis...), bipolar disorder, schizophrenia, severe depression or amyloidosis * Patient with history of previous atrial fibrillation ablation * Patient undergoing flutter ablation or atrial tachycardia ablation (not atrial fibrillation ablation) * Contraindication to atrial fibrillation ablation (intracardiac thrombus, severe pulmonary hypertension, mechanical mitral valve prosthesis or contraindication to anticoagulation,…) * Contraindication to antiarrhythmic drugs, or to implantable cardiac monitor * Patient with very advanced persistent atrial fibrillation, i.e., for more than 3 years or with a left atrial diameter \>60 mm in parasternal long axis section or a left atrial volume \> 48ml/m2 in echocardiography * Subject with a life expectancy of less than 24 months at study enrolment * Inability to consent * Persons benefiting from a reinforced protection, namely minors, persons deprived of liberty by a judicial or administrative decision, adults under legal protection, and finally patients in emergency situations * Pregnant or breastfeeding women, women at age to procreate and not using effective contraception (hormonal/barrier: oral, parenteral, percutaneous implantable, intrauterine device, or surgical: tubal ligation, hysterectomy, total ovariectomy)
Where it's running
-
CHU Angers
Angers, France Recruiting -
University Hospital
Brest, France Recruiting -
University Hospital
Caen, France Recruiting -
University Hospital
Dijon, France Recruiting -
CHU Grenoble
Grenoble, France Recruiting -
La Timone
Marseille, France Recruiting
Show 2 more locations
-
University Hospital
Poitiers, France Recruiting -
Centre Cardiologique du Nord
Saint-Denis, France Not yet recruiting
Study contacts
- Study coordinator: Rodrigue Garcia
- Email: rodrigue.garcia@chu-poitiers.fr
- Phone: 549443729
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Choose Myself (Before) Losing Myself
We’re testing an educational interactive booklet to help people with dementia or memory problems think about future medical decisions and start conversations with family or caregivers.
-
Gut and Oral Microbiome and Cognitive Health in Aging
This study tests whether differences in gut and mouth bacteria are linked to cognitive health in adults across ages and cognitive status.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
AI-supported sleep program for people with mild cognitive impairment or dementia
A small randomized trial tests an AI-assisted behavioral sleep program to help people with mild cognitive impairment or mild dementia who have sleep problems.
-
Binaural beats for cognitive function in older adults with mild cognitive impairment in nursing homes
This study tests whether listening to 10-Hz binaural beats for 30 minutes daily for 14 days can help cognitive function in older adults with mild cognitive impairment living in nursing homes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.